Imaging natural killer T cells in action

Immunology and Cell Biology

Volumn 91, Issue 4, 2013, Pages 304-310

  Wong, Connie H Y ^a   Kubes, Paul ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

imaging; innate immunity; liver; natural killer T cell

Indexed keywords

CD1D ANTIGEN; CYTOKINE; T LYMPHOCYTE RECEPTOR;

BORRELIA BURGDORFERI; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL MIGRATION; CELLULAR IMMUNITY; HOST PATHOGEN INTERACTION; HUMAN; IMAGING; IMMUNOMODULATION; IMMUNOREGULATION; INNERVATION; INTRAVITAL IMAGING; MICROSCOPY; MOLECULAR IMAGING; NATURAL KILLER T CELL; NONHUMAN; REVIEW; SPHINGOMONAS; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE ACTIVATION;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMAGING, THREE-DIMENSIONAL; NATURAL KILLER T-CELLS; NERVOUS SYSTEM;

ANIMALIA;

EID: 84876418530     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2013.6     Document Type: Review

References (77)

1. Bousso P, Robey E. Dynamics of CD8\+ T cell priming by dendritic cells in intact lymph nodes. Nat Immunol 2003; 4: 579-585.
2. Miller MJ, Wei SH, Parker I, Cahalan MD. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 2002; 296: 1869-1873.
3. Sumen C, Mempel TR, Mazo IB, von Andrian UH. Intravital microscopy: visualizing immunity in context. Immunity 2004; 21: 315-329.
4. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005; 23: 877-900.
5. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002; 2: 557-568.
6. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004; 114: 1379-1388.
7. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol 2004; 4: 231-237.
8. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25: 297-336.
9. Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest 2002; 110: 793-800.
10. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997; 15: 535-562.
11. Carlyle JR, Mesci A, Ljutic B, Belanger S, Tai LH, Rousselle E et al. Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of mouse NK cells. J Immunol 2006; 176: 7511-7524.
12. Slifka MK, Pagarigan RR, Whitton JL. NK markers are expressed on a high percentage of virus-specific CD8\+ and CD4\+ T cells. J Immunol 2000; 164: 2009-2015.
13. Taniguchi M, Seino K, Nakayama T. The NKT cell system: bridging innate and acquired immunity. Nat Immunol 2003; 4: 1164-1165.
14. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997; 278: 1626-1629.
15. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol 2004; 22: 817-890.
16. Blumberg RS, Gerdes D, Chott A, Porcelli SA, Balk SP. Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol Rev 1995; 147: 5-29.
17. Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P et al. CD1dmediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 1998; 188: 1521-1528.
18. Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8-T cells. J Exp Med 1994; 180: 1171-1176.
19. Park SH, Weiss A, Benlagha K, Kyin T, Teyton L, Bendelac A. The mouse CD1drestricted repertoire is dominated by a few autoreactive T cell receptor families. J Exp Med 2001; 193: 893-904.
20. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005; 434: 520-525.
21. Mattner J, Debord KL, Ismail N, Goff RD, Cantu III C, Zhou D et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005; 434: 525-529.
22. Kobayashi E, Motoki K, Uchida T, Fukushima H, Koezuka Y. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol Res 1995; 7: 529-534.
23. Yamaguchi Y, Motoki K, Ueno H, Maeda K, Kobayashi E, Inoue H et al. Enhancing effects of (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-2-(N- hexacosanoylamino)-1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells. Oncol Res 1996; 8: 399-407.
24. Liu Y, Goff RD, Zhou D, Mattner J, Sullivan BA, Khurana A et al. A modified alphagalactosyl ceramide for staining and stimulating natural killer T cells. J Immunol Methods 2006; 312: 34-39.
25. Uldrich AP, Patel O, Cameron G, Pellicci DG, Day EB, Sullivan LC et al. A semiinvariant Valpha10\+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties. Nat Immunol 2011; 12: 616-623.
26. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003; 21: 483-513.
27. Van Kaer L. NKT cells: T lymphocytes with innate effector functions. Curr Opin Immunol 2007; 19: 354-364.
28. Wilson SB, Delovitch TL. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat Rev Immunol 2003; 3: 211-222.
29. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007; 13: 139-145.
30. Crowe NY, Smyth MJ, Godfrey DI. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J Exp Med 2002; 196: 119-127.
31. Skold M, Behar SM. Role of CD1d-restricted NKT cells in microbial immunity. Infect Immun 2003; 71: 5447-5455.
32. Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001; 413: 531-534.
33. Sakuishi K, Oki S, Araki M, Porcelli SA, Miyake S, Yamamura T. Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation. J Immunol 2007; 179: 3452-3462.
34. Coquet JM, Kyparissoudis K, Pellicci DG, Besra G, Berzins SP, Smyth MJ et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol 2007; 178: 2827-2834.
35. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, Gapin L et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med 2003; 198: 1069-1076.
36. Au-Yeung BB, Fowell DJ. A key role for Itk in both IFN gamma and IL-4 production by NKT cells. J Immunol 2007; 179: 111-119.
37. Stanic AK, Bezbradica JS, Park JJ, Van Kaer L, Boothby MR, Joyce S. Cutting edge: the ontogeny and function of Va14Ja18 natural T lymphocytes require signal processing by protein kinase C theta and NF-kappa B. J Immunol 2004; 172: 4667-4671.
38. Townsend MJ, Weinmann AS, Matsuda JL, Salomon R, Farnham PJ, Biron CA et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 2004; 20: 477-494.
39. Wang ZY, Kusam S, Munugalavadla V, Kapur R, Brutkiewicz RR, Dent AL. Regulation of Th2 cytokine expression in NKT cells: unconventional use of Stat6, GATA-3, and NFAT2. J Immunol 2006; 176: 880-888.
40. Zullo AJ, Benlagha K, Bendelac A, Taparowsky EJ. Sensitivity of NK1.1-negative NKT cells to transgenic BATF defines a role for activator protein-1 in the expansion and maturation of immature NKT cells in the thymus. J Immunol 2007; 178: 58-66.
41. Lee PT, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med 2002; 195: 637-641.
42. Im JS, Arora P, Bricard G, Molano A, Venkataswamy MM, Baine I et al. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation. Immunity 2009; 30: 888-898.
43. Schmieg J, Yang G, Franck RW, Tsuji M. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-galactosylceramide. J Exp Med 2003; 198: 1631-1641.
44. Fujii S, Shimizu K, Kronenberg M, Steinman RM. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat Immunol 2002; 3: 867-874.
45. Barral P, Polzella P, Bruckbauer A, van Rooijen N, Besra GS, Cerundolo V et al. CD169(\+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat Immunol 2010; 11: 303-312.
46. Johnston B, Kim CH, Soler D, Emoto M, Butcher EC. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. J Immunol 2003; 171: 2960-2969.
47. Kim CH, Johnston B, Butcher EC. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(\+)V beta 11(\+) NKT cell subsets with distinct cytokine-producing capacity. Blood 2002; 100: 11-16.
48. Geissmann F, Cameron TO, Sidobre S, Manlongat N, Kronenberg M, Briskin MJ et al. Intravascular immune surveillance by CXCR6\+ NKT cells patrolling liver sinusoids. PLoS Biol 2005; 3: e113.
49. Lee WY, Kubes P. Leukocyte adhesion in the liver: distinct adhesion paradigm from other organs. J Hepatol 2008; 48: 504-512.
50. Wong CH, Jenne CN, Lee WY, Leger C, Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 2011; 334: 101-105.
51. Dustin ML, Bromley SK, Kan Z, Peterson DA, Unanue ER. Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc Natl Acad Sci USA 1997; 94: 3909-3913.
52. Velazquez P, Cameron TO, Kinjo Y, Nagarajan N, Kronenberg M, Dustin ML. Cutting edge: activation by innate cytokines or microbial antigens can cause arrest of natural killer T cell patrolling of liver sinusoids. J Immunol 2008; 180: 2024-2028.
53. Kastenmuller W, Torabi-Parizi P, Subramanian N, Lammermann T, Germain RN. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 2012; 150: 1235-1248.
54. de Lalla C, Galli G, Aldrighetti L, Romeo R, Mariani M, Monno A et al. Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J Immunol 2004; 173: 1417-1425.
55. Emoto M, Mittrucker HW, Schmits R, Mak TW, Kaufmann SH. Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4\+NKT cells. J Immunol 1999; 162: 5094-5098.
56. Thomas SY, Scanlon ST, Griewank KG, Constantinides MG, Savage AK, Barr KA et al. PLZF induces an intravascular surveillance program mediated by long-lived LFA-1-ICAM-1 interactions. J Exp Med 2011; 208: 1179-1188.
57. Barral P, Sanchez-Nino MD, van Rooijen N, Cerundolo V, Batista FD. The location of splenic NKT cells favours their rapid activation by blood-borne antigen. EMBO J 2012; 31: 2378-2390.
58. Kinjo Y, Illarionov P, Vela JL, Pei B, Girardi E, Li X et al. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 2011; 12: 966-974.
59. Lee WY, Moriarty TJ, Wong CH, Zhou H, Strieter RM, van Rooijen N et al. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat Immunol 2010; 11: 295-302.
60. Scanlon ST, Thomas SY, Ferreira CM, Bai L, Krausz T, Savage PB et al. Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation. J Exp Med 2011; 208: 2113-2124.
61. Wingender G, Rogers P, Batzer G, Lee MS, Bai D, Pei B et al. Invariant NKT cells are required for airway inflammation induced by environmental antigens. J ExpMed 2011; 208: 1151-1162.
62. Vultaggio A, Nencini F, Pratesi S, Petroni G, Romagnani S, Maggi E. Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation. Allergy 2012; 67: 1223-1232.
63. Kawahara K, Moll H, Knirel YA, Seydel U, Zahringer U. Structural analysis of two glycosphingolipids from the lipopolysaccharide-lacking bacterium Sphingomonas capsulata. Eur J Biochem 2000; 267: 1837-1846.
64. Wu D, Xing GW, Poles MA, Horowitz A, Kinjo Y, Sullivan B et al. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc Natl Acad Sci USA 2005; 102: 1351-1356.
65. Dieckmann R, Graeber I, Kaesler I, Szewzyk U, von Dohren H. Rapid screening and dereplication of bacterial isolates from marine sponges of the sula ridge by intactcell-MALDI-TOF mass spectrometry (ICM-MS). Appl Microbiol Biotechnol 2005; 67: 539-548.
66. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, Benhnia MR et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006; 7: 978-986.
67. Kumar H, Belperron A, Barthold SW, Bockenstedt LK. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol 2000; 165: 4797-4801.
68. Tupin E, Benhnia MR, Kinjo Y, Patsey R, Lena CJ, Haller MC et al. NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi. Proc Natl Acad Sci USA 2008; 105: 19863-19868.
69. Kawakami K, Yamamoto N, Kinjo Y, Miyagi K, Nakasone C, Uezu K et al. Critical role of Valpha14\+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur J Immunol 2003; 33: 3322-3330.
70. Nieuwenhuis EE, Matsumoto T, Exley M, Schleipman RA, Glickman J, Bailey DT et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med 2002; 8: 588-593.
71. Ishigami M, Nishimura H, Naiki Y, Yoshioka K, Kawano T, Tanaka Y et al. The roles of intrahepatic Valpha14(\+) NK1.1(\+) T cells for liver injury induced by Salmonella infection in mice. Hepatology 1999; 29: 1799-1808.
72. Shimizu H, Matsuguchi T, Fukuda Y, Nakano I, Hayakawa T, Takeuchi O et al. Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice. Gastroenterology 2002; 123: 1265-1277.
73. Steinman L. Elaborate interactions between the immune and nervous systems. Nat Immunol 2004; 5: 575-581.
74. Sanders VM. The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet? Brain Behav Immun 2012; 26: 195-200.
75. Minagawa M, Oya H, Yamamoto S, Shimizu T, Bannai M, Kawamura H et al. Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. Hepatology 2000; 31: 907-915.
76. Oya H, Kawamura T, Shimizu T, Bannai M, Kawamura H, Minagawa M et al. The differential effect of stress on natural killer T (NKT) and NK cell function. Clin Exp Immunol 2000; 121: 384-390.
77. Watarai H, Nakagawa R, Omori-Miyake M, Dashtsoodol N, Taniguchi M. Methods for detection, isolation and culture of mouse and human invariant NKT cells. Nat Protoc 2008; 3: 70-78.